Patient Recruitment and Enrollment in Clinical Trials

Finding participants for clinical trials is frequently more challenging than conducting the trials themselves. A delay in recruitment prolongs the study's timeline, pushing back the treatment's market availability. Take a look at the infographic below to grasp how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.Patient Recruitment and Enrollment InfographicDiscovering Clinical TrialsSeventy-two percent of participants are existing patients, while twenty-eight percent are new.Top sources of clinical trial information:Fifty-eight percent from primary care physicians40% from online registries30% from search engines19% from primary care nurses19% from pharmaceutical companiesMotivations for ParticipationTop perceived benefits:26% to advance medicineThirty-six percent to improve others' lives15% to improve their conditionEight percent as the best treatment optionFive percent for monetary compensationFactors influencing participation:Sixty percent physical locationSixty-three percent confidentiality73% types of procedures75% study purpose83% potential risks and benefitsEnrollment Challenges37% of sites under-enroll, with eleven percent failing to enroll any patients.Doubling original timelines helps ninety percent of trials meet enrollment goals.70% of the public haven't considered clinical trials, with nineteen percent unwilling to participate and seven percent unsure.Top perceived risks:40% side effectsThirty-three percent overall health risks7% receiving placebo7% stopping beneficial treatmentsForty patient recruitment company percent lack confidence in finding a suitable study, and 70% seldom consider clinical trials when discussing treatment options.However, there's optimism for improvement: Seventy-four percent are open to discussing trial participation in online peer communities, and 94% of volunteers would participate again.To learn more visit our website at https://recruitqualified.comPatient Recruitment and Enrollment in Clinical Trials